Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A

Paula Dibo1, Henrique Alexsander Ferreira Neves2, Raghunandan Konda3

  • 1Division of General Internal Medicine, Department of Medicine, Emory University, AtlantaGA, USA.

Glomerular Diseases
|May 11, 2026
PubMed
Abstract

Insights

The anti-serum phospholipase A2 receptor antibody (anti-PLA2R Ab) is linked to a higher risk of thromboembolism in primary membranous nephropathy (PMN) patients. This finding supports anti-PLA2R Ab as a potential biomarker for thrombogenesis in PMN.

Area of Science:

  • Nephrology
  • Immunology
  • Thrombosis

Background:

  • Primary membranous nephropathy (PMN) is a major cause of nephrotic syndrome in adults.
  • PMN is associated with an elevated risk of thromboembolic events.
  • The anti-serum phospholipase A2 receptor antibody (anti-PLA2R Ab) is specific to PMN and may promote a prothrombotic state.

Purpose of the Study:

  • To systematically review and meta-analyze the association between serum anti-PLA2R Ab and thromboembolic events in PMN patients.
  • To investigate the potential of anti-PLA2R Ab as a biomarker for thrombogenesis.

Main Methods:

  • Systematic search of PubMed, Embase, and Cochrane databases.
  • Inclusion of seven studies with 1,162 PMN patients.
  • Pooled analysis of odds ratios (ORs) and mean differences with 95% confidence intervals (CIs); heterogeneity assessed using I² statistics.

Main Results:

  • Patients with anti-PLA2R Ab had significantly higher odds of thromboembolism (OR 1.52; 95% CI 1.10, 2.09; p = 0.01).
  • Thromboembolism was associated with lower serum albumin (p = 0.003) but not proteinuria or age.
  • Higher total cholesterol levels were observed in anti-PLA2R Ab-positive patients (p < 0.0001).

Conclusions:

  • A significant association exists between anti-PLA2R Ab presence and thromboembolism risk in PMN.
  • Anti-PLA2R Ab may serve as a valuable biomarker for predicting thrombogenesis in PMN patients.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...